InsiderClue
Stocks · Health care · Pharmaceutical Preparations

PALVELLA THERAPEUTICS, INC.

PVLA Clue Score42
United States Fiscal year ends December CIK 0001583648
$138.77 +5.66% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $138.77 +97.99% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 16 Dec 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue5.8Operating income−22.8Net income−22.8Fiscal year 2017Revenue25.3 +333.5%Operating income−14.6Net income−17.6Fiscal year 2018Revenue27.2 +7.8%Operating income−30.8Net income−26.8Fiscal year 2019Revenue43.6 +60.2%Operating income−27.2Net income−25.5Fiscal year 2020Revenue29.3 −32.8%Operating income−33.9Net income−37.2EPS, diluted−0.68Fiscal year 2021Revenue31.4 +7.1%Operating income−51.8Net income−45.7EPS, diluted−0.71Fiscal year 2022Revenue25.9 −17.6%Operating income−43.5Net income−33.3Fiscal year 2023Revenue42.8 +65.3%Operating income−11.9Net income18.7EPS, diluted2.17Fiscal year 2024Operating income−14.1Net income−17.4 −193.3%EPS, diluted−7.83Fiscal year 2025Operating income−38.6Net income−41.7EPS, diluted−3.71
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 5.8 25.3 27.2 43.6 29.3 31.4 25.9 42.8 n/a n/a
Growth +333.5% +7.8% +60.2% −32.8% +7.1% −17.6% +65.3%
Operating income −22.8 −14.6 −30.8 −27.2 −33.9 −51.8 −43.5 −11.9 −14.1 −38.6
Net income −22.8 −17.6 −26.8 −25.5 −37.2 −45.7 −33.3 18.7 −17.4 −41.7
Growth −193.3%
EPS, diluted n/a n/a n/a n/a −0.68 −0.71 n/a 2.17 −7.83 −3.71

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−390.3%Net margin−391.0%Free cash flow margin−256.4%Fiscal year 2017Operating margin−57.7%Net margin−69.8%Free cash flow margin189.1%Fiscal year 2018Operating margin−113.1%Net margin−98.2%Free cash flow margin−10.1%Fiscal year 2019Operating margin−62.2%Net margin−58.4%Free cash flow margin−125.9%Fiscal year 2020Operating margin−115.7%Net margin−127.0%Free cash flow margin−165.8%Fiscal year 2021Operating margin−165.0%Net margin−145.6%Free cash flow margin−27.4%Fiscal year 2022Operating margin−167.8%Net margin−128.5%Free cash flow margin−235.4%Fiscal year 2023Operating margin−27.7%Net margin43.7%Free cash flow margin−32.4%Fiscal year 2024Fiscal year 2025
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −390.3% −57.7% −113.1% −62.2% −115.7% −165.0% −167.8% −27.7% n/a n/a
Net margin −391.0% −69.8% −98.2% −58.4% −127.0% −145.6% −128.5% 43.7% n/a n/a
Free cash flow margin −256.4% 189.1% −10.1% −125.9% −165.8% −27.4% −235.4% −32.4% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−14.4Capital expenditure−0.6Free cash flow−14.9Fiscal year 2017Operating cash flow49.8Capital expenditure−2.0Free cash flow47.8Fiscal year 2018Operating cash flow−1.1Capital expenditure−1.7Free cash flow−2.8 −105.8%Fiscal year 2019Operating cash flow−52.5Capital expenditure−2.5Free cash flow−54.9Fiscal year 2020Operating cash flow−45.9Capital expenditure−2.7Free cash flow−48.6Fiscal year 2021Operating cash flow−7.7Capital expenditure−0.9Free cash flow−8.6Fiscal year 2022Operating cash flow−59.9Capital expenditure−1.0Free cash flow−61.0Fiscal year 2023Operating cash flow−13.7Capital expenditure−0.2Free cash flow−13.9Fiscal year 2024Operating cash flow−10.8Fiscal year 2025Operating cash flow−25.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −14.4 49.8 −1.1 −52.5 −45.9 −7.7 −59.9 −13.7 −10.8 −25.0
Capital expenditure −0.6 −2.0 −1.7 −2.5 −2.7 −0.9 −1.0 −0.2 n/a n/a
Free cash flow −14.9 47.8 −2.8 −54.9 −48.6 −8.6 −61.0 −13.9 n/a n/a
Growth −105.8%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash29.4Shareholders’ equity25.2Fiscal year 2017Cash37.9Shareholders’ equity11.5Fiscal year 2018Cash74.9Shareholders’ equity39.9Fiscal year 2019Cash62.3Shareholders’ equity51.4Fiscal year 2020Cash70.4Shareholders’ equity31.0Fiscal year 2021Cash117.8Shareholders’ equity50.8Fiscal year 2022Cash38.6Shareholders’ equity−93.8Fiscal year 2023Cash7.4Shareholders’ equity−74.5Fiscal year 2024Cash83.6Shareholders’ equity62.6Fiscal year 2025Cash58.0Shareholders’ equity28.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 29.4 37.9 74.9 62.3 70.4 117.8 38.6 7.4 83.6 58.0
Shareholders’ equity 25.2 11.5 39.9 51.4 31.0 50.8 −93.8 −74.5 62.6 28.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023† 31 Dec 2023 FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
5.8 25.3 27.2 43.6 29.3 31.4 25.9 42.8 n/a n/a
Growth +333.5% +7.8% +60.2% −32.8% +7.1% −17.6% +65.3%
19.7 22.3 41.5 55.0 46.5 66.7 53.0 8.8 8.2 22.8
8.9 17.6 18.4 18.4 16.7 16.6 16.4 3.1 5.9 15.8
−22.8 −14.6 −30.8 −27.2 −33.9 −51.8 −43.5 −11.9 −14.1 −38.6
Growth
−22.6 −16.5 −27.1 −25.5 −37.1 −45.7 −33.3 18.7 −17.4 −41.7
0.2 1.1 −0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0
−22.8 −17.6 −26.8 −25.5 −37.2 −45.7 −33.3 18.7 −17.4 −41.7
Growth −193.3%
Per share
n/a n/a n/a n/a −0.68 −0.71 −0.45 2.19 −7.83 −3.71
n/a n/a n/a n/a −0.68 −0.71 n/a 2.17 −7.83 −3.71
Growth −460.8%
n/a n/a n/a n/a 54.5 64.5 74.2 1.8 2.2 11.3
n/a n/a n/a n/a 54.5 64.5 n/a 1.8 2.2 11.3
Growth +18.5% +24.1% +405.5%

† The diluted share count jumps at 2023 and 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 9.5% a year over five years.
  • Operating margin is up 85.4 points on five years ago, at -27.7%.
  • A net loss in 9 of 10 years on file.